Frankfurt - Delayed Quote EUR

Enlivex Therapeutics Ltd. (1BT.F)

Compare
1.0500
-0.0200
(-1.87%)
At close: 8:03:01 AM GMT+1

Research Analysis

Revenue vs. Earnings

Revenue --
Earnings -2.6M
Q4'23
Q1'24
Q2'24
Q3'24
-8M
-6M
-4M
-2M
0
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
No. of Analysts 2--22
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) 0.00%--0.00%0.00%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
1BT.F --------
S&P 500 9.01%10.57%14.00%13.70%

Upgrades & Downgrades

Maintains D. Boral Capital: Buy to Buy 12/11/2024
Maintains D. Boral Capital: Buy to Buy 12/3/2024
Maintains D. Boral Capital: Buy to Buy 11/14/2024
Reiterates HC Wainwright & Co.: Buy to Buy 9/27/2024
Maintains EF Hutton: Buy to Buy 9/26/2024
Maintains EF Hutton: Buy to Buy 9/24/2024

Related Tickers